The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Absence of c‐kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients
Abstract
Most sporadic gastrointestinal stromal tumours (GISTs) have somatic c‐kit gene mutations that are considered to be causal. Neurofibromatosis type 1 (NF1) is caused by mutations of the NF1 gene and NF1 patients have an increased risk of developing GISTs. Since most neoplasms are considered to develop as a result of the combination of several gene mutations, these findings suggest that GISTs from NF1 patients might have somatic c‐kit gene mutations and that sporadic GISTs from non‐NF1 patients might have somatic NF1 gene mutations. The present study analysed 29 GISTs from seven NF1 patients for c‐kit gene mutations and ten sporadic GISTs from ten non‐NF1 patients for NF1 mutations. Exons 9, 11, 13, and 17 of the c‐kit gene were amplified and directly sequenced after the extraction of genomic DNA from wax‐embedded tissues from 26 GISTs from five NF1 patients. The whole coding region of the c‐kit cDNA and the whole coding region of the NF1 cDNA were amplified and directly sequenced after RNA extraction and cDNA synthesis in three fresh GIST tissues from two NF1 patients and ten fresh GIST tissues from ten non‐NF1 patients. Of the ten sporadic GISTs, eight had heterozygous mutations at exon 11, and one at exon 9, of c‐kit. Heterozygous NF1 gene mutations were detected in GISTs from the two NF1 patients from whom fresh tissues were available. None of the 29 GISTs derived from NF1 patients had detectable c‐kit gene mutations and none of the ten GISTs derived from non‐NF1 patients had detectable NF1 mutations. These results suggest that the pathogenesis of GISTs in NF1 patients is different from that in non‐NF1 patients. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
Geissler, E. N., Ryan, M. A., & Housman, D. E. (1988) · Cell · doi:10.1016/0092-8674(88)90020-7 · Cited by 1,287
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095 · cited 2×
“NF1 gene product, neurofibromin, is a member of the GAP family of ras regulatory proteins [19].”
Background
Cited by
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Miettinen, M., & Lasota, J. (2006) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.09.001 · Cited by 2,052
Miettinen, M., & Lasota, J. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1466-gstrom · Cited by 1,459
Gastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,036
Gastrointestinal stromal tumours: origin and molecular oncology
Corless, C. L., Barnett, C. M., & Heinrich, M. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3143 · Cited by 891
Gastrointestinal stromal tumour
Joensuu, H., Hohenberger, P., & Corless, C. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60106-3 · Cited by 703
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Miettinen, M., Fetsch, J. F., Sobin, L. H., & Lasota, J. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176433.81079.bd · Cited by 507
Miettinen, M., Wang, Z.-F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., & Lasota, J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 363
Miettinen, M., Lasota, J., & Sobin, L. H. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000172190.79552.8b · Cited by 316
Corless, C. L., Ballman, K. V., Antonescu, C. R., Kolesnikova, V., Maki, R. G., Pisters, P. W. T., Blackstein, M. E., Blanke, C. D., Demetri, G. D., Heinrich, M. C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.2046 · Cited by 315
Andersson, J., Sihto, H., Meis-Kindblom, J. M., Joensuu, H., Nupponen, N., & Kindblom, L.-G. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000159775.77912.15 · Cited by 303
Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
Prieto-Granada, C. N., Wiesner, T., Messina, J. L., Jungbluth, A. A., Chi, P., & Antonescu, C. R. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000564 · Cited by 294
KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)
Lasota, J., & Miettinen, M. (2006) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.08.006 · Cited by 291
Prakash, S., Sarran, L., Socci, N., DeMatteo, R. P., Eisenstat, J., Greco, A. M., Maki, R. G., Wexler, L. H., LaQuaglia, M. P., Besmer, P., et al. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000157790.81329.47 · Cited by 271
Metadata
- Authors
- Kinoshita, K., Hirota, S., Isozaki, K., Ohashi, A., Nishida, T., Kitamura, Y., Shinomura, Y., & Matsuzawa, Y.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2003-11-18
- Volume
- 202
- Issue
- 1
- Pages
- 80-85
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2122573984
- Cited by
- 194
- References
- 3
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.